Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy-Reference-Cited by-同舟云学术

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Published:2021-05 Issue:5 Volume:35 Page:109071
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

DeVito Nicholas C.,Sturdivant Michael,Thievanthiran Balamayooran,Xiao Christine,Plebanek Michael P.,Salama April K.S.,Beasley Georgia M.,Holtzhausen Alisha,Novotny-Diermayr Veronica,Strickler John H.,Hanks Brent A.

Funder

Agency for Science Technology and Research

National Research Foundation of Singapore

Duke University School of Medicine

Merck & Co Inc

National Medical Research Council

National Institutes of Health

Damon Runyon Cancer Research Foundation

OncoMed Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference75 articles.

1. Sensitizing microsatellite stable colorectal cancer to immune checkpoint therapy utilizing Wnt pathway inhibition;Bagby;Cancer Res.,2020

2. Secreted frizzled-related protein 2 (sFRP2) redirects non-canonical wnt signaling from Fz7 to Ror2 during vertebrate gastrulation;Brinkmann;J. Biol. Chem.,2016

3. Regulatory T cells in the tumor microenvironment and cancer progression: Role and therapeutic targeting;Chaudhary;Vaccines (Basel),2016

4. Wnt/β-catenin signaling and disease;Clevers;Cell,2012

5. β-Catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas;Damsky;Cancer Cell,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade;Nature Nanotechnology;2024-08-26

2. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09

3. Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential;Heliyon;2024-08

4. Distinct tissue-niche localization and function of synovial tissue myeloid DC subsets in health, and in active and remission Rheumatoid Arthritis;2024-07-19

5. Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee;Journal for ImmunoTherapy of Cancer;2024-07